189 related articles for article (PubMed ID: 374283)
41. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids.
Huang MT; Wood AW; Newmark HL; Sayer JM; Yagi H; Jerina DM; Conney AH
Carcinogenesis; 1983 Dec; 4(12):1631-7. PubMed ID: 6360409
[TBL] [Abstract][Full Text] [Related]
42. Metabolism of the mutagenic environmental pollutant, 6-nitrobenzo[a]pyrene: metabolic activation via ring oxidation.
Fu PP; Chou MW; Yang SK; Beland FA; Kadlubar FF; Casciano DA; Heflich RH; Evans FE
Biochem Biophys Res Commun; 1982 Apr; 105(3):1037-43. PubMed ID: 7046751
[No Abstract] [Full Text] [Related]
43. Microsomal metabolism of 4-(N,N-diacetylamino)benzo[a]pyrene: a potent mutagenic arylamide derived from a carcinogenic polycyclic aromatic hydrocarbon.
Chou MW; Miller DW; Freeman JP; Fu PP
Chem Res Toxicol; 1988; 1(2):115-22. PubMed ID: 2979718
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of 1-nitrobenzo[a]pyrene by rat liver microsomes to potent mutagenic metabolites.
Chou MW; Heflich RH; Fu PP
Carcinogenesis; 1986 Nov; 7(11):1837-44. PubMed ID: 3769131
[TBL] [Abstract][Full Text] [Related]
45. Rat liver microsome-mediated binding of benzo(a)pyrene metabolites to DNA.
Thompson MH; King HW; Osborne MR; Brookes P
Int J Cancer; 1976 Feb; 17(2):270-4. PubMed ID: 1248906
[TBL] [Abstract][Full Text] [Related]
46. Mutagenicity of benzo(a)pyrenyl-1-sulfate in the Ames test.
Irwin SE; Kwei GY; Blackburn GR; Thurman R; Kauffman FC
Environ Mol Mutagen; 1992; 19(3):253-8. PubMed ID: 1572348
[TBL] [Abstract][Full Text] [Related]
47. Promutagen activation with mammalian and avian S9 liver microsomes.
Tometsko AM; Sheridan KM; DeTraglia MC
J Appl Toxicol; 1981 Feb; 1(1):11-4. PubMed ID: 6309943
[TBL] [Abstract][Full Text] [Related]
48. DIfferential ability of Ambystoma tigrinum hepatic microsomes to produce mutagenic metabolites from polycyclic aromatic hydrocarbons and aromatic amines.
Anderson RS; Döös EJ; Rose FL
Cancer Lett; 1982; 16(1):33-41. PubMed ID: 6288233
[TBL] [Abstract][Full Text] [Related]
49. The association of bacterial mutagenicity of hydrocarbon-derived 'bay-region' dihydrodiols with the Iball indices for carcinogenicity and with the extents of DNA-binding on mouse skin of the parent hydrocarbons.
Bartsch H; Malaveille C; Tierney B; Grover PL; Sims P
Chem Biol Interact; 1979 Jul; 26(2):185-96. PubMed ID: 110477
[TBL] [Abstract][Full Text] [Related]
50. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
Raina V; Williams CJ; Gurtoo HL
Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
[TBL] [Abstract][Full Text] [Related]
51. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
Kari FW; Kauffman FC; Thurman RG
Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
[TBL] [Abstract][Full Text] [Related]
52. Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of benzo(a)pyrene by rat liver microsomes.
Hara E; Kawajiri K; Tagashira Y
Cancer Res; 1983 Aug; 43(8):3604-8. PubMed ID: 6305488
[TBL] [Abstract][Full Text] [Related]
53. Sulfotransferase-mediated activation of 7,8,9,10-tetrahydro-7-ol, 7,8-dihydrodiol, and 7,8,9,10-tetraol derivatives of benzo[a]pyrene.
Surh YJ; Tannenbaum SR
Chem Res Toxicol; 1995; 8(5):693-8. PubMed ID: 7548751
[TBL] [Abstract][Full Text] [Related]
54. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
Jongeneelen FJ; Leijdekkers CM; Bos RP; Theuws JL; Henderson PT
J Appl Toxicol; 1985 Oct; 5(5):277-82. PubMed ID: 3902943
[TBL] [Abstract][Full Text] [Related]
55. Test-condition-dependent influence of harman and nonharman on benzo[a]pyrene mutagenesis in Salmonella.
Riebe M; Westphal K; Keller H
Mutat Res; 1982 Apr; 104(1-3):9-15. PubMed ID: 7043258
[TBL] [Abstract][Full Text] [Related]
56. Effects of unsaturated fatty acids on metabolism of benzo[a]pyrene in an NADPH-fortified rat liver microsomal system.
Nemoto N; Takayama S
Carcinogenesis; 1983 Oct; 4(10):1253-7. PubMed ID: 6311450
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of covalent DNA binding and mutagenicity of benzo[a]pyrene by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl) carbamoyl]acetate (YH439), a novel hepatoprotective agent.
Surh YJ; Shlyankevich M; Lee JW; Yoo JK
Mutat Res; 1996 Apr; 367(4):219-24. PubMed ID: 8628328
[TBL] [Abstract][Full Text] [Related]
58. The homogeneity of rat liver microsomal cytochrome P-448 activity and its role in the activation of benzo[a]pyrene to mutagens.
Phillipson CE; Ioannides C; Barrett DC; Parke DV
Int J Biochem; 1985; 17(1):37-42. PubMed ID: 3996731
[TBL] [Abstract][Full Text] [Related]
59. Fluorescence study of DNA-binding metabolites of benzo(a)pyrene formed in hepatocytes isolated from 3-methylcholanthrene-treated rats.
Jernström B; Orrenius S; Undeman O; Gräslund A; Ehrenberg A
Cancer Res; 1978 Aug; 38(8):2600-7. PubMed ID: 667854
[TBL] [Abstract][Full Text] [Related]
60. S-Adenosyl-L-methionine is a carbon donor in the conversion of benzo[alpha]pyrene to 6-hydroxymethylbenzo[alpha]pyrene by rat liver S-9.
Flesher JW; Stansbury KH; Sydnor KL
Cancer Lett; 1982; 16(1):91-4. PubMed ID: 6288234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
